Tuesday, March 11, 2014 8:44:37 PM
From the time a patient decides to enroll until they get scheduled runs about three months. It may still be a month to six weeks until they actually get implanted.
The fact they are reporting three patients last quarter, was already released weeks ago.
There is no issue with patient enrollment. The implanted number of patients being reported will lag throughout the trial.
Actually the current rate of enrollment is what lead me to decide to be bullish on C-pulse. That and the early favorable feedback from surgeons about the ease of implantation.
At any rate, I am now in. Will add more at $6 and $5.50 if we retrace that far.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM